NEULAND LABORATORIES
Back to Income Statement
|
NEULAND LABORATORIES Last 5 Year Total Expenditure History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹1,448 Cr | ₹1,154 Cr | ₹1,096 Cr | ₹919 Cr | ₹808 Cr |
What is the latest Total Expenditure of NEULAND LABORATORIES ?
| Year | Total Expenditure |
|---|---|
| Mar2026 | ₹1,448 Cr |
| Mar2025 | ₹1,154 Cr |
| Mar2024 | ₹1,096 Cr |
| Mar2023 | ₹919 Cr |
| Mar2022 | ₹808 Cr |
How is Total Expenditure of NEULAND LABORATORIES Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,448 Cr | 25.56 | |
| Mar2025 | ₹1,154 Cr | 5.25 | |
| Mar2024 | ₹1,096 Cr | 19.21 | |
| Mar2023 | ₹919 Cr | 13.72 | |
| Mar2022 | ₹808 Cr | - | |
Compare Total Expenditure of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹28,807.2 Cr | 4.7% | 18.5% | 79% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,271.0 Cr | -0.5% | -0.3% | 18.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,843.0 Cr | 3.1% | 18.9% | 33.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,000.0 Cr | -1.5% | -1.6% | 35.6% | Stock Analytics | |
| CIPLA | ₹118,072.0 Cr | -0.9% | 1.6% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,073.0 Cr | 2% | -3.8% | -0.7% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 4.7% |
18.5% |
79% |
| SENSEX | -0.8% |
0.5% |
-3.8% |
You may also like the below Video Courses